Risk Factors Associated with Infant Deaths from Pertussis: A Case-Control Study

Clinical Infectious Diseases

Volumn 61, Issue 7, 2015, Pages 1099-1106

  Winter, Kathleen ^a   Zipprich, Jennifer ^a   Harriman, Kathleen ^a   Murray, Erin L ^a   Gornbein, Jeffrey ^b   Hammer, Sandra Jo ^a   Yeganeh, Nava ^c   Adachi, Kristina ^c   Cherry, James D ^c  

^a Immunization Branch   (United States)

^b Statistical Biomathematical Consulting Clinic Department of Biomathematics   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

infant pertussis; leukocytosis; lymphocytosis; pneumonia; pulmonary hypertension

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MACROLIDE; NITRIC OXIDE; STEROID;

ARTICLE; CASE CONTROL STUDY; CHILD DEATH; CONTROLLED STUDY; ENCEPHALITIS; EXCHANGE BLOOD TRANSFUSION; EXTRACORPOREAL OXYGENATION; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; INTUBATION; LEUKOCYTE COUNT; LOW BIRTH WEIGHT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; OXYGEN SATURATION; PERTUSSIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE RATE; RISK FACTOR; SEIZURE; ADULT; COMPLICATION; LEUKOCYTOSIS; LYMPHOCYTOSIS; MORTALITY; NEWBORN; WHOOPING COUGH; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; LEUKOCYTOSIS; LYMPHOCYTOSIS; MALE; PNEUMONIA; RISK FACTORS; WHOOPING COUGH; YOUNG ADULT;

EID: 84941074500     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ472     Document Type: Article

References (40)

1. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984; 14:1-78
2. Cherry JD. The present and future control of pertussis. Clin Infect Dis 2010; 51:663-7
3. Cherry JD. Epidemic pertussis in 2012-the resurgence of a vaccinepreventable disease. N Engl J Med 2012; 367:785-7
4. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326-82
5. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22:628-34
6. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012; 161:1091-6
7. Winter K, Glaser C, Watt J, Harriman K. Pertussis epidemic-California, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:1129-32
8. Cherry JD, Harrison R, Bradely JS; American Academy of Pediatrics. California District IX. Pertussis in young infants. Available at: www.aap-ca.org/clinical/pertussis/pertussis-in-young-infants.html. Accessed 1 April 2015
9. Briand V, Bonmarin I, Levy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine 2007; 25:7224-32
10. Mikelova LK, Halperin SA, Scheifele D, et al. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003; 143:576-81
11. Wortis N, Strebel PM, Wharton M, Bardenheier B, Hardy IR. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 1996; 97:607-12
12. Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J 2009; 28:194-8
13. Murray E, Nieves D, Bradley JS, et al. Characteristics of severe Bordetella pertussis infection among infants ≤90 days of age admitted to pediatric intensive care units-southern California. J Pediatr Infect Dis Soc 2013; 2:1-6
14. Marshall H, Clarke M, Rasiah K, et al. Predictors of diseases severity in children hospitalized for pertussis during an epidemic. Pediatr Infect Dis J 2015; 34:339-45
15. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 2004; 46(RR-10):1-55
16. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the RPART routines. Technical report. Rochester, MI: Mayo Foundation, 1997
17. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Belmont, CA: Wadsworth, 1983
18. Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis: implications for immunization. Expert Rev Vaccines 2014; 13:1115-23
19. Christie CD, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199-202
20. Nieves D, Bradley JS, Gargas J, et al. Exchange blood transfusion in the management of severe pertussis in young infants. Pediatr Infect Dis J 2013; 32:698-9
21. Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328-38
22. Rowlands HE, Goldman AP, Harrington K, et al. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics 2010; 126:e816-27
23. Sawal M, Cohen M, Irazuzta JE, et al. Fulminant pertussis: a multicenter study with new insights into the clinico-pathological mechanisms. Pediatr Pulmonol 2009; 44:970-80
24. DeGeorge BR Jr, Gao E, Boucher M, et al. Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress. Circulation 2008; 117: 1378-87
25. Foerster K, Groner F, Matthes J, Koch WJ, Birnbaumer L, Herzig S. Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors. Proc Natl Acad Sci U S A 2003; 100:14475-80
26. Adamson PB, Hull SS Jr, Vanoli E, et al. Pertussis toxin-induced ADP ribosylation of inhibitor G proteins alters vagal control of heart rate in vivo. Am J Physiol 1993; 265:H734-40
27. Centers for Disease Control and Prevention. 2014 recommended immunizations for children from birth through 6 years old. Available at: http://www.cdc.gov/vaccines/parents/downloads/parent-ver-sch-0-6yrs.pdf. Accessed 1 April 2015
28. Edwards KM, Bradley RB, Decker MD, et al. Evaluation of a new highly purified pertussis vaccine in infants and children. J Infect Dis 1989; 160:832-7
29. Podda A, Carapella De Luca E, Titone L, et al. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children. J Pediatr 1993; 123:81-4
30. Podda A, De Luca EC, Titone L, et al. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12-to 24-and 2-to 4-month-old children. J Pediatr 1992; 120:680-5
31. Juretzko P, von Kries R, Hermann M, Wirsing von Konig CH, Weil J, Giani G. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis 2002; 35:162-7
32. Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance. Vaccine 2012; 30:3239-47
33. Centers for Disease Control and Prevention. Tdap for pregnant women: information for providers. 2014. Available at: http://www.cdc.gov/vaccines/ vpd-vac/pertussis/tdap-pregnancy-hcp.htm. Accessed 1 April 2015
34. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384:1521-8
35. Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis 2015; 60:333-7
36. Cherry JD. Tetanus-diphtheria-pertussis immunization in pregnant women and the prevention of pertussis in young infants. Clin Infect Dis 2015; 60:338-40
37. Flak TA, Goldman WE. Autotoxicity of nitric oxide in airway disease. Am J Respir Crit Care Med 1996; 154:S202-6
38. Goldman W. Tracheal cytotoxin of Bordetella pertussis. In:Wardlaw AC, John PR, eds. Pathogens and immunity in pertussis. Hoboken, NJ: John Wiley & Sons Ltd, 1988:237-46
39. Mallory FB, Hornor AA. Pertussis: the histological lesion in the respiratory tract. J Med Res 1912; 27:115-243
40. Iida T, Kunitani A, Komase Y, Yamamoto A. Studies on experimental infection with Bordetella pertussis, effect of cortisone on the infection and immunity in mice. Jpn J Exp Med 1963; 33:282-95